GT Biopharma director Anthony Cataldo resigns from board

GT Biopharma, Inc.

Anthony Cataldo resigned as a member of the Board of Directors on December 15, 2021.
Filing provides no reason for resignation or any details about a successor.
The resignation reduces the board size; no immediate replacement announced.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Anthony Cataldo

Director

GTBP · GT Biopharma, Inc.

Effective: 2021-12-15
Filed: December 21, 2021, 6:59 PM ET

On December 15, 2021, Anthony Cataldo resigned as a member of the Registrant’s Board of Directors.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Anthony Cataldo resigned as Director at GT Biopharma, Inc..

Action: resigned
Role: Director

Exact text from the filing

On December 15, 2021, Anthony Cataldo resigned as a member of the Registrant’s Board of Directors.

View on SEC.gov

GT Biopharma, Inc. filing history →

Source: SEC EDGAR

accession 0001654954-21-013424

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.